Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Hematology|October 9, 2013
Recombinant human soluble thrombomodulin is active against hemophagocytic lymphohistiocytosis associated with acquired immunodeficiency syndromeSungGi Chi, Takayuki Ikezoe, Asako Takeuchi, et al.
Leukemia Research|June 11, 2015
STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cellsAsako Takeuchi, Chie Nishioka, Takayuki Ikezoe, et al.
European Journal of Pharmacology|July 31, 2007
Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in ratsToshiyuki Funatsu, Asako Takeuchi, Takuya Hirata, et al.
The Journal of Dermatology|November 1, 2018
High-grade trichoblastic carcinoma arising through malignant transformation of trichoblastoma: Immunohistochemical analysis and the expression of p53 and phosphorylated AKTTakayuki Fusumae, Keiji Tanese, Asako Takeuchi, et al.
International Journal of Cancer|December 4, 2010
Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34+ /CD38- cells and sensitizes them to antileukemia agentsTakayuki Ikezoe, Jing Yang, Chie Nishioka, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 5, 2014
[Successful eculizumab treatment for multiple coronary thrombosis complicated in paroxysmal nocturnal hemoglobinuria]Ayuko Taniguchi, Takayuki Ikezoe, Asako Takeuchi, et al.
European Journal of Pharmacology|May 6, 2008
Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in ratsTakuya Hirata, Yoshihiro Keto, Mari Nakata, et al.
International Journal of Cancer|January 6, 2011
Expression of p-JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemiaTakayuki Ikezoe, Shinsuke Kojima, Mutsuo Furihata, et al.
Leukemia Research Reports|December 30, 2020
Successful treatment with <i>ABL</i> tyrosine kinase inhibitor for patients with acute myeloid leukemia with <i>BCR-ABL1</i>Asako Takeuchi, Toshinori Kondo, Taizo Tasaka, et al.
European Journal of Haematology|August 20, 2013
Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantationTakayuki Ikezoe, Asako Takeuchi, SungGi Chi, et al.
Pageof 2